<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="9764">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01705405</url>
  </required_header>
  <id_info>
    <org_study_id>DCIC 12 06</org_study_id>
    <nct_id>NCT01705405</nct_id>
  </id_info>
  <brief_title>Merging of Endoscopic and Ultrasound Images for Laparoscopic Surgery</brief_title>
  <acronym>FEE</acronym>
  <official_title>Merging of Endoscopic and Ultrasound Images for Laparoscopic Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AdministrateurCIC</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>TIMC-IMAG</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Clinical Investigation Centre for Innovative Technology Network</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Grenoble</source>
  <oversight_info>
    <authority>France: Agence Nationale de Sécurité du Médicament et des produits de santé</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Visualize surgical needles inserted in the prostate, under the ultrasound modality.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In order to help the surgeon to remove the prostate during a laparoscopic intervention, our
      goal is to provide an innovative medical device that merges intra-operative ultrasound and
      endoscopic images.

      We have already achieved the proof of concept of a device that merges ultrasound and
      endoscopic images. The objectives of this clinical trial are to accompany the maturation of
      the fusion device and to make the initial assessments of its Medical Service.

      The main difficulty is to visualize markers (surgical needles) under both modalities , in
      order to merge them.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2012</start_date>
  <completion_date type="Anticipated">September 2015</completion_date>
  <primary_completion_date type="Anticipated">February 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Single Group Assignment, Masking: Open Label</study_design>
  <primary_outcome>
    <measure>Percent of surgical needles visible under the ultrasound modality (once inserted in the prostate)</measure>
    <time_frame>1year</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percent of data(ultrasound and endoscopic) on which the merging works</measure>
    <time_frame>1year</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percent of accurate merging</measure>
    <time_frame>1year</time_frame>
    <safety_issue>No</safety_issue>
    <description>the merging is accurate if its error is under 5mm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percent of mistaken segmentation of the vesical neck in the endoscopic image</measure>
    <time_frame>1year</time_frame>
    <safety_issue>No</safety_issue>
    <description>The segmentation in the endoscopic image is mistaken if it differs of more than 5mm² from the segmentation in the ultrasound volume</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Prostate Cancer</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Software for acquiring ultrasound and endoscopic images</intervention_name>
    <description>Use of a medical device to acquire ultrasound and endoscopic images</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  of-age patient

          -  patient for whom a radical prostatectomy is planned

          -  patient with a prostate volume between 30g and 100g

          -  patient affiliated to the social security or equivalent

          -  Written informed consent

        Exclusion Criteria:

          -  contraindication

          -  patient who has undergone a significant prostate resection

          -  patient who has undergone a prostate irradiation

          -  patient concerned by the L1121-6 à 8 of the health public code
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Alexandre Long, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Grenoble</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jean-Alexandre Long, MD</last_name>
    <email>margaux.janier@imag.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Urology, University hospital of Grenoble</name>
      <address>
        <city>Grenoble</city>
        <state>Isère</state>
        <zip>38000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Alexandre Long, MD</last_name>
      <email>margaux.janier@imag.fr</email>
    </contact>
    <investigator>
      <last_name>Jean-Jacques Rambeaud, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean-Luc Descottes, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alexis Arvin-Berod, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <link>
    <url>http://www.cic-it-grenoble.fr/</url>
    <description>Related Info</description>
  </link>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 10, 2014</lastchanged_date>
  <firstreceived_date>October 5, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Grenoble</investigator_affiliation>
    <investigator_full_name>AdministrateurCIC</investigator_full_name>
    <investigator_title>principal investigator</investigator_title>
  </responsible_party>
  <keyword>cancer</keyword>
  <keyword>prostate</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Prostatic Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
